10522

Fluka

 

Anisomycin from Streptomyces griseolus

BioChemika, ≥96.0% (TLC)

Synonym:(2R,3S,4S)-2-(4-Methoxybenzyl)-3,4-pyrrolidinediol-3-acetate, 2-[(4-Methoxyphenyl)methyl]-3,4-pyrrolidinediol 3-acetate, Flagecidin
CAS Number:22862-76-6
Linear Formula:C14H19NO4
Molecular Weight:265.30
Beilstein Registry Number:20705
EC Number:245-269-7
MDL number:MFCD00077650

Description

Other NotesInhibits formation of the 80S ribosomal complex from 60S subunits.1
Biochem/physiol ActionsAntibiotic isolated from Streptomyces griseolus that inhibits protein synthesis. Acts by inhibiting peptidyl transferase activity in eukaryote ribosomes. Reported to induce apoptosis in a variety of cells including promyelocytic leukemia cells, Jurkat cells, ventricular myocytes, and colon adenocarcinoma cells. Initiates intracellular signals and immediate early gene induction. Selective signaling agonist. Potent Jun-NH2 terminal kinase (JNK) agonist. Activates mitogen-activated protein (MAP) kinases (JNK/SAPK and p38/RK). Antiprotozoal agent.

Properties

product lineBioChemika
assay≥96.0% (TLC)
solubilitymethanol: 20 mg/mL, clear, colorless to faintly yellow
storage temp.2-8°C

Safety

Personal Protective EquipmentEyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
Hazard CodesT
Risk Statements25
Safety Statements45
RIDADRUN3462 6.1/PG 3
WGK Germany3
RTECSBZ9800000

Related Products

Replaced byA9789, Anisomycin from Streptomyces griseolus

References

Cited Reference1. W.J.van Venrooij et al. Biochemistry 16, 2343, (1977) Abstract
MerckMerck 13,673
BeilsteinBeil. 21,V,5,523